Chlamydia pneumoniae antigens facilitate experimental aortic dilatation: Prevention with azithromycin

Journal of Vascular Surgery

Volumn 36, Issue 5, 2002, Pages 1011-1017

  Tambiah, Jeymi ^a   Powell, Janet T ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIAL POLYSACCHARIDE; CALCIUM CHLORIDE; CARPROFEN; FORMALDEHYDE; MEMBRANE ANTIGEN;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ANTIINFLAMMATORY ACTIVITY; AORTA WALL; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL DIET; CONTROLLED STUDY; DNA DETERMINATION; ECHOGRAPHY; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MACROPHAGE MIGRATION; NONHUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; RABBIT;

EID: 0036845324     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.128928     Document Type: Article

References (34)

1. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2(8618):983-6.
2. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
3. Strachan DP, Carrington D, Mendall MA, Ballam L, Morris J, Butland BK, et al. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study. Br Med J 1999;318:1035-40.
4. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997;350:430-6.
5. Thomas M, Wong Y, Thomas D, Ajaz M, Tsang V, Gallagher PJ, et al. Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation 1999;99:2733-6.
6. Vink A, Poppen M, Schoneveld AH, Roholl PJ, de Kleijn DP, Borst C, et al. Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 2001;103:1613-7.
7. Kol A, Sukhova G, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-α and matrix metalloproteinase expression. Circulation 1998;98:300-7.
8. Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A, et al. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression. Circulation 1999;100:1369-73.
9. Davies MJ, Woolf N. Atherosclerosis: What is it and why does it occur? Br Heart J 1993;69:S3-11.
10. Shah PK. Inflammation, metalloproteinases and increased proteolysis: An emerging pathological paradigm in aortic aneurysm. Circulation 1997;96:2115-7.
11. Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, Surcel H-M, et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg 1997;25:499-505.
12. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor-Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implication. J Clin Pathol 1996;49:102-6.
13. Petersen E, Boman J, Persson K, Arnerlov C, Wadell G, Juto P, et al. Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1998;15:138-42.
14. Meijer A, van Der Vliet JA, Roholl PJ, Gielis-Proper SK, de Vries A, Ossewaarde JM. Chlamydia pneumoniae in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 1999;19:2680-6.
15. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996;125:979-82.
16. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, et al. Infections with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
17. Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD, Pearson RR, et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Preliminary results of the ACADEMIC study. Circulation 2000;102:1755-60.
18. Ridker PM. On evolutionary biology, inflammation, infection and the causes of atherosclerosis. Circulation 2002;105:2-4.
19. Mosorini M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M, et al. Use of doxycycline to decrease the growth rate of abdominal aneurysms: A randomized, double-blind, placebo-controlled study. J Vasc Surg 2001;34:757-8.
20. Freestone T, Turner RJ, Higman DJ, Lever MJ, Powell JT. Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysms in rabbits. Arterioscler Thromb Vasc Biol 1997;17:10-7.
21. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
22. Grayston TJ. Secondary prevention antibiotic therapy treatment trials for coronary artery disease. Circulation 2000;102:1742-5.
23. Walton LJ, Franklin IJ, Bayston T, Brown LC, Greenhalgh RM, Taylor GW, et al. Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms. Circulation 1999;100:48-54.
24. Parchure N, Zouridakis EG, Kaski JC. Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. Circulation 2002;105:1298-303.
25. Miralles M, Webster W, Sicard GA, Thompson R, Reilly JM. Indomethacin inhibits expansion of experimental aortic aneurysm via inhibition of the cox2 isoform of cyclooxygenase. J Vasc Surg 1999;29:884-92.
26. Aalto-Setälä K, Laitinen K, Erkkilä L, Leinonen M, Jauhiainen M, Ehnholm C, et al. Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2001;21:578.
27. Caligiuri G, Rottenberg M, Nicoletti A, Wigzell H, Hansson GK. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 2001;103:2834-8.
28. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999;283:1335-9.
29. Christiansen D, Boesen T, Hjerno K, Daugaard L, Mygind P, Madsen AS, et al. Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity. Am Heart J 1999;138:S491-5.
30. Meijer A, van Der Vliet JA, Roholl PJ, Gielis-Proper SK, de Vries A, Ossewaarde JM. Chlamydia pneumoniae in abdominal aortic aneurysms: Abundance of membrane components in the absence of heat shock protein 60 and DNA. Arterioscler Thromb Vasc Biol 1999;19:2680-6.
31. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-9.
32. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, et al. Production and localization of 92-kelodalton gelatinase in abdominal aortic aneurysms. J Clin Invest 1995;96:318-26.
33. Vehmaan-Kreula P, Puolakkainen M, Sarvas M, Welgus HG, Kovanen PT. Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 2001;21:E1-8.
34. Gertz DS, Kurgan A, Eisenberg D. Aneurysm of the rabbit common carotid artery induced by periarterial application of calcium chloride in vivo. J Clin Invest 1988;81:649-56.